RTI Surgical (NSDQ:RTIX) today released results from a study of its SImmetry sacroiliac joint fusion system, touting that it produces effective joint fixation with a reduced range of motion in the SI joint.
Results from the study were published in The Spine Journal, the Alachua, Fla.-based company said.
In the study, researchers compared two minimally-invasive techniques for placing primary and secondary threaded implants to compare effectiveness at stabilizing the SI joint. Investigators also explored the impact of removing the secondary implant on construct rigidity.
Data from the study indicated that the SImetry implants provided a 65-71% reduction in joint motion which was maintained after repeated loading, the company said.
“These results reinforce the effectiveness of the SImmetry System in aiding patients who suffer from chronic low back pain caused by SI joint dysfunction. The SImmetry System is the only minimally-invasive surgical procedure that promotes SI joint fusion through decortication, reducing the range of motion in all directions with only two implants,” prez & CEO Camille Farhat said in a press release.
RTI Surgical said it recently acquired the SImmetery system in efforts to invest in advanced spinal surgery innovations.
Earlier this month, RTI Surgical put black ink into the ledger for 2017 and pared its fourth-quarter losses in its earnings release.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.